摘要
回眸2009年中的高血压治疗领域,虽无重要临床试验结果发表,但有更多的反思,且反思的力度之强为近年来少有,很可能会影响今后的降压治疗策略:①降压-获益的J型曲线问题;②强化降压有益还是有害;③利尿剂的降压地位受质疑;④高血压指南的动向。
Reviewing on the treatment of hypertension in 2009,even if no important clinical trials results were published,but there are more reflections,and reflection intensity is rare in recent years,is likely to affect the future strategies for antihypertensive therapy:1. Anti-hypertensive treatment and the J-curve. 2. Is enhanced hypotension benef icial or harmful? 3. The positions of diuretics in hypotension have been questioned. 4. New horizons in treatment guidelines for hypertension.
出处
《中国处方药》
2009年第12期34-36,共3页
Journal of China Prescription Drug